Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

NCT07432932 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT07432932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07432932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Recruiting
Start date
November 19, 2021
Completion date
June 30, 2028
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angiosarcoma, leiomyosarcoma (lms), liposarcoma, liposarcoma, dedifferentiated, retroperitoneal sarcoma, sarcoma, sarcoma, leiomyo-, adult, sarcoma, synovial, adult, soft tissue sarcoma (sts), soft tissue sarcoma adult, soft tissue sarcoma of the limb, soft tissue sarcoma of the trunk and extremities